Tapewire

Nasdaq · USD

RARE

Ultragenyx Pharmaceutical Inc.

Export transactions ↓
Tapewire entity
4337
SEC CIK
0001515673
Parsed reports
478

Last 12 months

Inside the activity.

0 purchase rows · 27 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202502
Jan 202601
Feb 202601
Mar 2026011
Apr 202601
May 202603
Jun 202603
Jul 202601
Aug 202602
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2020 Filed Mar 4, 2020 00:58 UTC
KAKKIS EMIL DDirector · President & CEO
GrantStock Option (Right to Buy) · Derivative 56,100 $0.00 Strike: $56.08 $0.00
Disclosure

SEC source: 0001209191-20-015760 · doc4.xml · derivative · entry 5

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,100

Underlying: Common Stock · 56,100 shares

Expires 2030-03-01

F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:58 UTC
KAKKIS EMIL DDirector · President & CEO
Tax withholdingCommon Stock 6,896 $56.08 $386,727.68
Disclosure

SEC source: 0001209191-20-015760 · doc4.xml · nonDerivative · entry 3

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 504,800

F4 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:58 UTC
KAKKIS EMIL DDirector · President & CEO
GrantCommon Stock 18,782 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015760 · doc4.xml · nonDerivative · entry 2

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 511,696

F3 · shares: Represents 6,198 shares of common stock and 12,584 RSUs which previously granted performance stock units were converted on March 1, 2020 upon certification of the performance metric. The RSUs will fully vest on March 1, 2021.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:58 UTC
KAKKIS EMIL DDirector · President & CEO
GrantCommon Stock 17,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015760 · doc4.xml · nonDerivative · entry 1

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 492,914

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:45 UTC
Bedrosian Camille LEVP and Chief Medical Officer
GrantStock Option (Right to Buy) · Derivative 21,000 $0.00 Strike: $56.08 $0.00
Disclosure

SEC source: 0001209191-20-015735 · doc4.xml · derivative · entry 4

Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Common Stock · 21,000 shares

Expires 2030-03-01

F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:45 UTC
Bedrosian Camille LEVP and Chief Medical Officer
Tax withholdingCommon Stock 1,249 $56.08 $70,043.92
Disclosure

SEC source: 0001209191-20-015735 · doc4.xml · nonDerivative · entry 3

Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,300

F4 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:45 UTC
Bedrosian Camille LEVP and Chief Medical Officer
GrantCommon Stock 5,634 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015735 · doc4.xml · nonDerivative · entry 2

Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,549

F3 · shares: Represents 1,859 shares of common stock and 3,775 RSUs into which previously granted performance stock units were converted on March 1, 2020 upon certification of the performance metric. The RSUs will fully vest on March 1, 2021.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:45 UTC
Bedrosian Camille LEVP and Chief Medical Officer
GrantCommon Stock 7,300 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015735 · doc4.xml · nonDerivative · entry 1

Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,915

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:46 UTC
Sharp ShaliniCFO & Executive Vice President
Tax withholdingCommon Stock 2,325 $56.08 $130,386.00
Disclosure

SEC source: 0001209191-20-015736 · doc4.xml · nonDerivative · entry 2

Sharp Shalini · CIK 0001377202 · CFO & Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,832

F3 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:46 UTC
Sharp ShaliniCFO & Executive Vice President
GrantCommon Stock 5,634 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015736 · doc4.xml · nonDerivative · entry 1

Sharp Shalini · CIK 0001377202 · CFO & Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,157

F1 · shares: Represents 1,859 shares of common stock and 3,775 restricted stock units ("RSUs") into which previously granted performance stock units were converted on March 1, 2020 upon certification of the performance metric. The RSUs will fully vest on March 1, 2021.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:02 UTC
Harris ErikEVP & Chief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 22,000 $0.00 Strike: $56.08 $0.00
Disclosure

SEC source: 0001209191-20-015766 · doc4.xml · derivative · entry 4

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 22,000 shares

Expires 2030-03-01

F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:02 UTC
Harris ErikEVP & Chief Commercial Officer
Tax withholdingCommon Stock 824 $56.08 $46,209.92
Disclosure

SEC source: 0001209191-20-015766 · doc4.xml · nonDerivative · entry 3

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,572

F4 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:02 UTC
Harris ErikEVP & Chief Commercial Officer
GrantCommon Stock 3,287 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015766 · doc4.xml · nonDerivative · entry 2

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,396

F3 · shares: Represents 1,085 shares of common stock and 2,202 RSUs into which previously granted performance stock units were converted on March 1, 2020 upon certification of the performance metric. The RSUs will fully vest on March 1, 2021.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:02 UTC
Harris ErikEVP & Chief Commercial Officer
GrantCommon Stock 7,800 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015766 · doc4.xml · nonDerivative · entry 1

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,109

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:00 UTC
Parschauer Karah HerdmanEVP and General Counsel
GrantStock Option (Right to Buy) · Derivative 22,000 $0.00 Strike: $56.08 $0.00
Disclosure

SEC source: 0001209191-20-015763 · doc4.xml · derivative · entry 4

Parschauer Karah Herdman · CIK 0001677455 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 22,000 shares

Expires 2030-03-01

F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:00 UTC
Parschauer Karah HerdmanEVP and General Counsel
Tax withholdingCommon Stock 2,118 $56.08 $118,777.44
Disclosure

SEC source: 0001209191-20-015763 · doc4.xml · nonDerivative · entry 3

Parschauer Karah Herdman · CIK 0001677455 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,400

F4 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:00 UTC
Parschauer Karah HerdmanEVP and General Counsel
GrantCommon Stock 5,634 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015763 · doc4.xml · nonDerivative · entry 2

Parschauer Karah Herdman · CIK 0001677455 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,518

F3 · shares: Represents 1,859 shares of common stock and 3,775 RSUs into which previously granted performance stock units were converted on March 1, 2020 upon certification of the performance metric. The RSUs will fully vest on March 1, 2021.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 01:00 UTC
Parschauer Karah HerdmanEVP and General Counsel
GrantCommon Stock 7,800 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015763 · doc4.xml · nonDerivative · entry 1

Parschauer Karah Herdman · CIK 0001677455 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,884

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:56 UTC
Huizenga Theodore AlanSVP, Controller and PAO
GrantStock Option (Right to Buy) · Derivative 7,480 $0.00 Strike: $56.08 $0.00
Disclosure

SEC source: 0001209191-20-015757 · doc4.xml · derivative · entry 3

Huizenga Theodore Alan · CIK 0001603347 · SVP, Controller and PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,480

Underlying: Common Stock · 7,480 shares

Expires 2030-03-01

F4 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:56 UTC
Huizenga Theodore AlanSVP, Controller and PAO
Tax withholdingCommon Stock 388 $56.08 $21,759.04
Disclosure

SEC source: 0001209191-20-015757 · doc4.xml · nonDerivative · entry 2

Huizenga Theodore Alan · CIK 0001603347 · SVP, Controller and PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,058

F3 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:56 UTC
Huizenga Theodore AlanSVP, Controller and PAO
GrantCommon Stock 1,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015757 · doc4.xml · nonDerivative · entry 1

Huizenga Theodore Alan · CIK 0001603347 · SVP, Controller and PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,446

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:55 UTC
Huang Dennis KarlEVP & Chief Tech Ops Officer
GrantStock Option (Right to Buy) · Derivative 22,000 $0.00 Strike: $56.08 $0.00
Disclosure

SEC source: 0001209191-20-015752 · doc4.xml · derivative · entry 4

Huang Dennis Karl · CIK 0001641217 · EVP & Chief Tech Ops Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 22,000 shares

Expires 2030-03-01

F6 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:55 UTC
Huang Dennis KarlEVP & Chief Tech Ops Officer
Tax withholdingCommon Stock 1,779 $56.08 $99,766.32
Disclosure

SEC source: 0001209191-20-015752 · doc4.xml · nonDerivative · entry 3

Huang Dennis Karl · CIK 0001641217 · EVP & Chief Tech Ops Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,475

F4 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

F5 · balance_after: Includes 241 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2019.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:55 UTC
Huang Dennis KarlEVP & Chief Tech Ops Officer
GrantCommon Stock 5,634 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015752 · doc4.xml · nonDerivative · entry 2

Huang Dennis Karl · CIK 0001641217 · EVP & Chief Tech Ops Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,013

F3 · shares: Represents 1,859 shares of common stock and 3,775 RSUs into which previously granted performance stock units were converted on March 1, 2020 upon certification of the performance metric. The RSUs will fully vest on March 1, 2021.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:55 UTC
Huang Dennis KarlEVP & Chief Tech Ops Officer
GrantCommon Stock 7,800 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015752 · doc4.xml · nonDerivative · entry 1

Huang Dennis Karl · CIK 0001641217 · EVP & Chief Tech Ops Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,379

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:53 UTC GrantStock Option (Right to Buy) · Derivative 22,000 $0.00 Strike: $56.08 $0.00
Disclosure

SEC source: 0001209191-20-015750 · doc4.xml · derivative · entry 4

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 22,000 shares

Expires 2030-03-01

F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:53 UTC Tax withholdingCommon Stock 3,085 $56.08 $173,006.80
Disclosure

SEC source: 0001209191-20-015750 · doc4.xml · nonDerivative · entry 3

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,487

F4 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:53 UTC GrantCommon Stock 5,634 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015750 · doc4.xml · nonDerivative · entry 2

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,572

F3 · shares: Represents 1,859 shares of common stock and 3,775 RSUs into which previously granted performance stock units were converted on March 1, 2020 upon certification of the performance metric. The RSUs will fully vest on March 1, 2021.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 4, 2020 00:53 UTC GrantCommon Stock 7,800 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-015750 · doc4.xml · nonDerivative · entry 1

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,938

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2020 Filed Mar 5, 2020 00:44 UTC Amendment
Huizenga Theodore AlanSVP, Controller and PAO
GrantStock Option (Right to Buy) · Derivative 13,280 $0.00 Strike: $56.08 $0.00
Disclosure

SEC source: 0001209191-20-016374 · doc4a.xml · derivative · entry 2

Huizenga Theodore Alan · CIK 0001603347 · SVP, Controller and PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,280

Underlying: Common Stock · 13,280 shares

Expires 2030-03-01

F3 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2020 Filed Mar 5, 2020 00:44 UTC Amendment
Huizenga Theodore AlanSVP, Controller and PAO
GrantCommon Stock 4,400 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-016374 · doc4a.xml · nonDerivative · entry 1

Huizenga Theodore Alan · CIK 0001603347 · SVP, Controller and PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,958

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
January 30, 2020 Filed Jan 31, 2020 18:58 UTC
Bedrosian Camille LEVP and Chief Medical Officer
Tax withholdingCommon Stock 1,624 $53.23 $86,445.52
Disclosure

SEC source: 0001209191-20-005730 · doc4.xml · nonDerivative · entry 1

Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,615

F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
January 14, 2020 Filed Jan 15, 2020 18:08 UTC
Huizenga Theodore AlanSVP, Controller and PAO
SaleCommon Stock 1,000 $61.00 $61,000.00
Disclosure

SEC source: 0001209191-20-003425 · doc4.xml · nonDerivative · entry 1

Huizenga Theodore Alan · CIK 0001603347 · SVP, Controller and PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,946

F1 · kind: The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

F3 · balance_after: Includes 161 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 31, 2019

Read SEC document
October 14, 2019 Filed Oct 16, 2019 23:29 UTC GrantCommon Stock 1,434 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-053325 · doc4.xml · nonDerivative · entry 1

Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,675

F1 · shares: Represents restricted stock units (RSUs) into which previously granted performance stock units were converted on October 14, 2019 upon certification of the applicable performance metric. Half of these RSUs will vest on the first anniversary of the certification date and the other half will vest on the second anniversary of the certification date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2019 Filed Oct 16, 2019 23:30 UTC
KAKKIS EMIL DDirector · President & CEO
GrantCommon Stock 3,435 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-053326 · doc4.xml · nonDerivative · entry 1

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 475,914

F1 · shares: Represents restricted stock units (RSUs) into which previously granted performance stock units were converted on October 14, 2019 upon certification of the applicable performance metric. Half of these RSUs will vest on the first anniversary of the certification date and the other half will vest on the second anniversary of the certification date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2019 Filed Oct 16, 2019 23:24 UTC
Bedrosian Camille LEVP and Chief Medical Officer
GrantCommon Stock 1,437 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-053321 · doc4.xml · nonDerivative · entry 1

Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,239

F1 · shares: Represents restricted stock units (RSUs) into which previously granted performance stock units were converted on October 14, 2019 upon certification of the applicable performance metric. Half of these RSUs will vest on the first anniversary of the certification date and the other half will vest on the second anniversary of the certification date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2019 Filed Oct 16, 2019 23:25 UTC
Sharp ShaliniCFO & Executive Vice President
GrantCommon Stock 1,434 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-053322 · doc4.xml · nonDerivative · entry 1

Sharp Shalini · CIK 0001377202 · CFO & Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,523

F1 · shares: Represents restricted stock units (RSUs) into which previously granted performance stock units were converted on October 14, 2019 upon certification of the applicable performance metric. Half of these RSUs will vest on the first anniversary of the certification date and the other half will vest on the second anniversary of the certification date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2019 Filed Oct 16, 2019 23:21 UTC
Huizenga Theodore AlanSVP, Controller and PAO
GrantCommon Stock 800 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-053320 · doc4.xml · nonDerivative · entry 1

Huizenga Theodore Alan · CIK 0001603347 · SVP, Controller and PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,785

F1 · shares: Represents restricted stock units (RSUs) into which previously granted performance stock units were converted on October 14, 2019 upon certification of the applicable performance metric. Half of these RSUs will vest on the first anniversary of the certification date and the other half will vest on the second anniversary of the certification date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2019 Filed Oct 16, 2019 23:32 UTC
Harris ErikEVP & Chief Commercial Officer
GrantCommon Stock 1,208 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-053328 · doc4.xml · nonDerivative · entry 1

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,309

F1 · shares: Represents restricted stock units (RSUs) into which previously granted performance stock units were converted on October 14, 2019 upon certification of the applicable performance metric. Half of these RSUs will vest on the first anniversary of the certification date and the other half will vest on the second anniversary of the certification date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2019 Filed Oct 16, 2019 23:31 UTC
Huang Dennis KarlEVP & Chief Tech Ops Officer
GrantCommon Stock 1,434 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-053327 · doc4.xml · nonDerivative · entry 1

Huang Dennis Karl · CIK 0001641217 · EVP & Chief Tech Ops Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,579

F1 · shares: Represents restricted stock units (RSUs) into which previously granted performance stock units were converted on October 14, 2019 upon certification of the applicable performance metric. Half of these RSUs will vest on the first anniversary of the certification date and the other half will vest on the second anniversary of the certification date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2019 Filed Oct 16, 2019 23:28 UTC
Parschauer Karah HerdmanEVP and General Counsel
GrantCommon Stock 1,434 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-053324 · doc4.xml · nonDerivative · entry 1

Parschauer Karah Herdman · CIK 0001677455 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,084

F1 · shares: Represents restricted stock units (RSUs) into which previously granted performance stock units were converted on October 14, 2019 upon certification of the applicable performance metric. Half of these RSUs will vest on the first anniversary of the certification date and the other half will vest on the second anniversary of the certification date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2019 Filed Oct 16, 2019 23:27 UTC GrantCommon Stock 1,434 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-053323 · doc4.xml · nonDerivative · entry 1

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,138

F1 · shares: Represents restricted stock units (RSUs) into which previously granted performance stock units were converted on October 14, 2019 upon certification of the applicable performance metric. Half of these RSUs will vest on the first anniversary of the certification date and the other half will vest on the second anniversary of the certification date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 04, 2019 Filed Oct 7, 2019 23:40 UTC
Hogenhuis WladimirChief Operating Officer
Tax withholdingCommon Stock 1,297 $44.52 $57,742.44
Disclosure

SEC source: 0001209191-19-052722 · doc4.xml · nonDerivative · entry 1

Hogenhuis Wladimir · CIK 0001755074 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,703

F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
September 16, 2019 Filed Sep 17, 2019 23:25 UTC
Sharp ShaliniCFO & Executive Vice President
Exercise / conversionStock Option (Right to Buy) · Derivative 24,880 $0.00 Strike: $6.86 $0.00
Disclosure

SEC source: 0001209191-19-049950 · doc4.xml · derivative · entry 4

Sharp Shalini · CIK 0001377202 · CFO & Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,998

Underlying: Common Stock · 24,880 shares

Expires 2023-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/4th of the option vested one year from November 1, 2013 and then 1/48th of the option vested monthly thereafter.

Read SEC document
September 16, 2019 Filed Sep 17, 2019 23:25 UTC
Sharp ShaliniCFO & Executive Vice President
Exercise / conversionStock Option (Right to Buy) · Derivative 6,963 $0.00 Strike: $0.81 $0.00
Disclosure

SEC source: 0001209191-19-049950 · doc4.xml · derivative · entry 3

Sharp Shalini · CIK 0001377202 · CFO & Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,963 shares

Expires 2022-08-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/4th of the option vested one year from May 21, 2012 and then 1/48th of the option vested monthly thereafter.

Read SEC document
September 16, 2019 Filed Sep 17, 2019 23:25 UTC
Sharp ShaliniCFO & Executive Vice President
Exercise / conversionCommon Stock 24,880 $6.86 $170,676.80
Disclosure

SEC source: 0001209191-19-049950 · doc4.xml · nonDerivative · entry 2

Sharp Shalini · CIK 0001377202 · CFO & Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,089

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
September 16, 2019 Filed Sep 17, 2019 23:25 UTC
Sharp ShaliniCFO & Executive Vice President
Exercise / conversionCommon Stock 6,963 $0.81 $5,640.03
Disclosure

SEC source: 0001209191-19-049950 · doc4.xml · nonDerivative · entry 1

Sharp Shalini · CIK 0001377202 · CFO & Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,209

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
September 11, 2019 Filed Sep 11, 2019 16:35 UTC
KAKKIS EMIL DDirector · President & CEO
PurchaseCommon Stock 5,000 $43.63 $218,150.00
Disclosure

SEC source: 0001209191-19-049117 · doc4.xml · nonDerivative · entry 1

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 472,479

Read SEC document
July 16, 2019 Filed Jul 17, 2019 21:02 UTC Tax withholdingCommon Stock 649 $59.17 $38,401.33
Disclosure

SEC source: 0001209191-19-042404 · doc4.xml · nonDerivative · entry 1

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,704

F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
July 06, 2019 Filed Jul 9, 2019 23:40 UTC
Harris ErikEVP & Chief Commercial Officer
Tax withholdingCommon Stock 260 $59.51 $15,472.60
Disclosure

SEC source: 0001209191-19-041642 · doc4.xml · nonDerivative · entry 1

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,101

F1 · shares: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.